Oncology

Mark Anderson, M.D.

Salem, MA

Dr. Mark Anderson is a cardiovascular disease specialist at Dana-Farber Cancer Institute specializing in General hematology/oncology.

Concierge Match Report

Is Dr. Anderson right for you?

We'll build a personalized evaluation of Dr. Anderson for your case, side-by-side against the top alternatives in their subspecialty.

In-depth evaluation of Dr. Anderson for your specific case
Side-by-side comparison vs. the top alternatives

Fully credited toward membership if you join within 30 days

$25

Start my Match Report — $25

Credentials

Board Certifications

Hematology
Internal Medicine
Medical Oncology

Education & Training

Jefferson Medical College of Thomas Jefferson University (MD)
Lankenau Hospital, Internal Medicine (Residency)
University of Connecticut Health Center, Hematology and Oncology (Fellowship)

Peer Recognition

Healthgrades — Healthgrades Honor Roll

Clinical Focus

Subspecialties

Medical Oncology

Conditions & Treatments

Chemotherapy

Insurance(s) Accepted

Please verify your coverage with the provider — plan participation can change.

Practice Details

Hospital Affiliations

Dana-Farber Cancer Institute
Wentworth-douglass Hospital
Massachusetts General Hospital
North Shore Medical Center

Conditions Dr. Anderson treats

Chemotherapy

Frequently asked

Does Dr. Anderson accept Aetna insurance?

Mark Anderson's public profile lists Aetna, Amerigroup (Wellpoint), and Anthem Blue Cross Blue Shield plus 23 more health plans as accepted plans. Plan participation can change — confirm directly with the practice before your visit.

Where does Dr. Anderson practice?

Mark Anderson practices in Salem, MA with hospital affiliations including Dana-Farber Cancer Institute, Wentworth-douglass Hospital, and Massachusetts General Hospital.

What does Dr. Anderson specialize in?

Mark Anderson is a board-certified oncology specialist with focus areas in Medical Oncology.

What is Dr. Anderson's medical training?

Public profile training history includes: Jefferson Medical College of Thomas Jefferson University (MD); Lankenau Hospital, Internal Medicine (Residency); University of Connecticut Health Center, Hematology and Oncology (Fellowship).